Invention Grant
- Patent Title: HIF-1 and HIF-2 inhibitors
-
Application No.: US16072803Application Date: 2017-01-27
-
Publication No.: US10962549B2Publication Date: 2021-03-30
- Inventor: Ali Tavassoli
- Applicant: University of Southampton
- Applicant Address: GB Southampton
- Assignee: University of Southampton
- Current Assignee: University of Southampton
- Current Assignee Address: GB Southampton
- Agency: Parker Highlander PLLC
- Priority: GB1601527 20160127
- International Application: PCT/GB2017/050220 WO 20170127
- International Announcement: WO2017/129997 WO 20170803
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61K38/08 ; A61P35/00 ; C07K14/47 ; C07K7/06 ; C07K7/02 ; G01N33/68

Abstract:
The present invention relates to inhibitors of HIF-1 and HIF-2 and uses thereof. The present invention further relates to the inhibitors for use in treatment of diseases. An isolated polypeptide is provided, that prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and/or inhibits the activity of HIF-1 and HIF-2, wherein the polypeptide comprises the amino acid sequence C-X1-X2-X3-Z-X4 (SEQ ID NO 1) and wherein X1, X2, X3 and X4 are any amino acid and wherein Z is leucine, valine of isoleucine or a non-natural derivative or leucine, valine or isoleucine. The isolated polypeptide prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and inhibits the activity of HIF-1 and HIF-2 by binding to HIF-1α or HIF-1β and/or HIF-2α or HIF-1β.
Public/Granted literature
- US20190033318A1 HIF-1 AND HIF-2 INHIBITORS Public/Granted day:2019-01-31
Information query
IPC分类: